Compare AEO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEO | CDNA |
|---|---|---|
| Founded | 1977 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2004 | 2007 |
| Metric | AEO | CDNA |
|---|---|---|
| Price | $17.90 | $66.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $18.55 | ★ $58.83 |
| AVG Volume (30 Days) | ★ 6.2M | 1.0M |
| Earning Date | 09-09-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.92 | ★ 2.13 |
| Revenue | ★ $5,547,236,000.00 | $48,324,000.00 |
| Revenue This Year | $5.54 | $30.36 |
| Revenue Next Year | $3.42 | $6.23 |
| P/E Ratio | ★ $19.88 | $30.04 |
| Revenue Growth | 4.10 | ★ 18.93 |
| 52 Week Low | $14.06 | $13.95 |
| 52 Week High | $28.46 | $65.50 |
| Indicator | AEO | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 62.04 | 78.88 |
| Support Level | $16.87 | $17.26 |
| Resistance Level | $18.50 | N/A |
| Average True Range (ATR) | 0.62 | 2.87 |
| MACD | 0.33 | 0.90 |
| Stochastic Oscillator | 85.52 | 99.39 |
American Eagle Outfitters Inc is a specialty retailer. The company is engaged in the retail of apparel and accessories with company stores in the United States, Canada, Mexico, and Hong Kong. The Company leases all store premises, regional distribution facilities, some of its office space, and certain information technology and office equipment. American Eagle also has its online business. It operates in two segments: American Eagle and Aerie. The majority of its revenue comes from its primary brand, American Eagle, which offers an assortment of specialty apparel, accessories, and personal care products for women and men. Geographically, it generates the majority of its revenue from the United States.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.